• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特异性抗荚膜抗体对荚膜型新生隐球菌的调理作用。

Opsonization of encapsulated Cryptococcus neoformans by specific anticapsular antibody.

作者信息

Kozel T R, Follette J L

出版信息

Infect Immun. 1981 Mar;31(3):978-84. doi: 10.1128/iai.31.3.978-984.1981.

DOI:10.1128/iai.31.3.978-984.1981
PMID:7014468
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC351414/
Abstract

Antisera prepared in rabbits against either whole encapsulated cells of Cryptococcus neoformans or purified cryptococcal polysaccharide were opsonic for the encapsulated yeast. The opsonic activity was removed by absorption with whole cryptococci and was inhibited by free polysaccharide. As little as 0.13 microgram of cryptococcal polysaccharide produced a 50% inhibition of opsonization. Various degrees of neutralization by polysaccharides from the four cryptococcal serotypes suggested that the opsonins were type specific. Fractionation of antiserum on Bio-Gel A-5m (Bio-Rad Laboratories) and diethylaminoethyl cellulose showed that the opsonins were antibodies of the immunoglobulin G class. These opsonizing antibodies did not require heat-labile serum components for optimal phagocytosis of the yeast. Inhibition studies using 2-deoxy-D-glucose demonstrated that ingestion of encapsulated cryptococci opsonized with anticapsular antibody was a 2-deoxy-D-glucose-inhibitable process. This result differed from similar studies with non-encapsulated cryptococci which showed that ingestion of non-encapsulated cryptococci opsonized with normal serum was not inhibited by 2-deoxy-D-glucose.

摘要

用兔制备的抗血清,无论是针对新型隐球菌的全包膜细胞还是纯化的隐球菌多糖,对包膜酵母均有调理作用。调理活性可通过与全隐球菌吸收而去除,并被游离多糖抑制。低至0.13微克的隐球菌多糖可产生50%的调理抑制作用。来自四种隐球菌血清型的多糖的不同程度的中和作用表明调理素具有型特异性。在Bio-Gel A-5m(伯乐公司)和二乙氨基乙基纤维素上对抗血清进行分级分离表明,调理素是免疫球蛋白G类抗体。这些调理抗体在酵母的最佳吞噬作用中不需要热不稳定的血清成分。使用2-脱氧-D-葡萄糖的抑制研究表明,摄入用抗荚膜抗体调理的包膜隐球菌是一个2-脱氧-D-葡萄糖可抑制的过程。这一结果与对非包膜隐球菌的类似研究不同,后者表明摄入用正常血清调理的非包膜隐球菌不受2-脱氧-D-葡萄糖抑制。

相似文献

1
Opsonization of encapsulated Cryptococcus neoformans by specific anticapsular antibody.特异性抗荚膜抗体对荚膜型新生隐球菌的调理作用。
Infect Immun. 1981 Mar;31(3):978-84. doi: 10.1128/iai.31.3.978-984.1981.
2
Opsonization of Cryptococcus neoformans by human immunoglobulin G: role of immunoglobulin G in phagocytosis by macrophages.人免疫球蛋白G对新型隐球菌的调理作用:免疫球蛋白G在巨噬细胞吞噬作用中的作用。
Infect Immun. 1979 Jul;25(1):255-61. doi: 10.1128/iai.25.1.255-261.1979.
3
The capsule of cryptococcus neoformans passively inhibits phagocytosis of the yeast by macrophages.新型隐球菌的荚膜可被动抑制巨噬细胞对酵母的吞噬作用。
J Immunol. 1982 Oct;129(4):1675-80.
4
Opsonization of Cryptococcus neoformans by human immunoglobulin G: masking of immunoglobulin G by cryptococcal polysaccharide.人免疫球蛋白G对新型隐球菌的调理作用:隐球菌多糖对免疫球蛋白G的掩盖作用
Infect Immun. 1979 Jul;25(1):262-7. doi: 10.1128/iai.25.1.262-267.1979.
5
Fc-dependent and Fc-independent opsonization of Cryptococcus neoformans by anticapsular monoclonal antibodies: importance of epitope specificity.抗荚膜单克隆抗体对新型隐球菌的Fc依赖性和非Fc依赖性调理作用:表位特异性的重要性
Infect Immun. 2002 Jun;70(6):2812-9. doi: 10.1128/IAI.70.6.2812-2819.2002.
6
Concomitant but not causal association between surface charge and inhibition of phagocytosis by cryptococcal polysaccharide.隐球菌多糖的表面电荷与吞噬作用抑制之间存在伴随但非因果的关联。
Infect Immun. 1980 Aug;29(2):295-300. doi: 10.1128/iai.29.2.295-300.1980.
7
Activation and binding of opsonic fragments of C3 on encapsulated Cryptococcus neoformans by using an alternative complement pathway reconstituted from six isolated proteins.通过使用由六种分离蛋白重构的替代补体途径,C3调理素片段在荚膜新生隐球菌上的激活与结合。
Infect Immun. 1989 Jul;57(7):1922-7. doi: 10.1128/iai.57.7.1922-1927.1989.
8
Phagocytosis of Cryptococcus neoformans by normal and thioglycolate-activated macrophages.正常巨噬细胞和巯基乙酸盐激活的巨噬细胞对新型隐球菌的吞噬作用。
Infect Immun. 1978 Sep;21(3):714-20. doi: 10.1128/iai.21.3.714-720.1978.
9
Opsonization of Cryptococcus neoformans by a family of isotype-switch variant antibodies specific for the capsular polysaccharide.针对荚膜多糖的一类同种型转换变体抗体对新型隐球菌的调理作用。
Infect Immun. 1990 Jun;58(6):1914-8. doi: 10.1128/iai.58.6.1914-1918.1990.
10
Localization on encapsulated Cryptococcus neoformans of serum components opsonic for phagocytosis by macrophages and neutrophils.血清成分对巨噬细胞和中性粒细胞吞噬新生隐球菌的调理作用的定位。
Infect Immun. 1984 Feb;43(2):574-9. doi: 10.1128/iai.43.2.574-579.1984.

引用本文的文献

1
Adaptive Immunity to Infections.对感染的适应性免疫
J Fungi (Basel). 2017;3(4). doi: 10.3390/jof3040064. Epub 2017 Nov 21.
2
Cryptococcus neoformans: historical curiosity to modern pathogen.新型隐球菌:从历史奇闻到现代病原体
Yeast. 2014 Feb;31(2):47-60. doi: 10.1002/yea.2997. Epub 2014 Jan 19.
3
A sensitive high-throughput assay for evaluating host-pathogen interactions in Cryptococcus neoformans infection.一种用于评估新型隐球菌感染中宿主-病原体相互作用的敏感高通量检测方法。
PLoS One. 2011;6(7):e22773. doi: 10.1371/journal.pone.0022773. Epub 2011 Jul 28.
4
Cryptococcal interactions with the host immune system.新型隐球菌与宿主免疫系统的相互作用。
Eukaryot Cell. 2010 Jun;9(6):835-46. doi: 10.1128/EC.00039-10. Epub 2010 Apr 9.
5
Opsonic requirements for dendritic cell-mediated responses to Cryptococcus neoformans.树突状细胞介导的对新型隐球菌反应的调理素需求。
Infect Immun. 2005 Jan;73(1):592-8. doi: 10.1128/IAI.73.1.592-598.2005.
6
Monoclonal antibodies reactive with immunorecessive epitopes of glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformans.与新型隐球菌主要荚膜多糖葡糖醛酸木甘露聚糖的免疫隐性表位发生反应的单克隆抗体。
Clin Diagn Lab Immunol. 2003 Sep;10(5):903-9. doi: 10.1128/cdli.10.5.903-909.2003.
7
Contribution of epitope specificity to the binding of monoclonal antibodies to the capsule of Cryptococcus neoformans and the soluble form of its major polysaccharide, glucuronoxylomannan.表位特异性对单克隆抗体与新型隐球菌荚膜及其主要多糖葡糖醛酸木糖甘露聚糖可溶性形式结合的贡献。
Clin Diagn Lab Immunol. 2003 Mar;10(2):252-8. doi: 10.1128/cdli.10.2.252-258.2003.
8
Acute lethal toxicity following passive immunization for treatment of murine cryptococcosis.被动免疫治疗小鼠隐球菌病后的急性致死毒性。
Infect Immun. 1997 May;65(5):1800-7. doi: 10.1128/iai.65.5.1800-1807.1997.
9
Quantitative analysis of phagocytosis and killing of Cryptococcus neoformans by human peripheral blood mononuclear cells by flow cytometry.采用流式细胞术对人外周血单个核细胞吞噬和杀伤新型隐球菌进行定量分析。
Clin Diagn Lab Immunol. 1995 Nov;2(6):753-9. doi: 10.1128/cdli.2.6.753-759.1995.
10
Prevalence in Cryptococcus neoformans strains of a polysaccharide epitope which can elicit protective antibodies.新型隐球菌菌株中可引发保护性抗体的多糖表位的流行情况。
Clin Diagn Lab Immunol. 1994 Nov;1(6):737-40. doi: 10.1128/cdli.1.6.737-740.1994.

本文引用的文献

1
Nonencapsulated Variant of Cryptococcus neoformans I. Virulence Studies and Characterization of Soluble Polysaccharide.新型隐球菌非包被变异株 I. 毒力研究及可溶性多糖的特性。
Infect Immun. 1971 Feb;3(2):287-94. doi: 10.1128/iai.3.2.287-294.1971.
2
CRYPTOCOCCUS NEOFORMANS POLYSACCHARIDE: STUDIES OF SEROLOGIC PROPERTIES AND ROLE IN INFECTION.新型隐球菌多糖:血清学特性及其在感染中作用的研究
J Immunol. 1965 Jun;94:916-20.
3
Formation of histiocyte rings in response to Cryptococcus neoformans infection.对新型隐球菌感染的反应中组织细胞环的形成。
J Reticuloendothel Soc. 1965 Sep;2(3):249-55.
4
Serodiagnosis of clinical cryptococcosis.临床隐球菌病的血清学诊断
Am Rev Respir Dis. 1968 Feb;97(2):275-82. doi: 10.1164/arrd.1968.97.2.275.
5
Experimental murine cryptococcosis: effect of hyperimmunization to capsular polysaccharide.实验性小鼠隐球菌病:对荚膜多糖进行超免疫的效果
J Immunol. 1967 May;98(5):914-22.
6
Serology of human cryptococcosis.人类隐球菌病的血清学
Ann Intern Med. 1968 Jul;69(1):45-52. doi: 10.7326/0003-4819-69-1-45.
7
Immunofluorescence studies of reactions at the Cryptococcal capsule.隐球菌荚膜反应的免疫荧光研究。
J Infect Dis. 1968 Apr;118(2):215-29. doi: 10.1093/infdis/118.2.215.
8
Prognostic factors in cryptococcal meningitis. A study in 111 cases.隐球菌性脑膜炎的预后因素。111例病例研究。
Ann Intern Med. 1974 Feb;80(2):176-81. doi: 10.7326/0003-4819-80-2-176.
9
The role of the classical and alternate complement pathways in host defenses against Cryptococcus neoformans infection.经典补体途径和替代补体途径在宿主抵御新型隐球菌感染中的作用。
J Immunol. 1974 Jun;112(6):2260-70.
10
Immune response to Cryptococcus neoformans soluble polysaccharide. I. Serological assay for antigen and antibody.对新型隐球菌可溶性多糖的免疫反应。I. 抗原和抗体的血清学检测
Infect Immun. 1972 Jan;5(1):35-41. doi: 10.1128/iai.5.1.35-41.1972.